Evotec SE

Healthcare

NASDAQ:EVO · NASDAQ Global Select

Market Cap $966.11M Beta 1.30 P/E (TTM) -4.4

$2.72 +0.00%

+$0.00 today

52W Low $2.31High $4.42

Vol 0.01M · Avg 0.09M

EPS (TTM)-$1.09

Drug Manufacturers - Specialty & Generic

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-36.30%

Period High

$4.34

Period Low

$2.31

Latest

$2.72

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Spyre Therapeutics, Inc.

NASDAQ:SYRE

$4.88B

Pharvaris N.V.

NASDAQ:PHVS

$2.15B

NovoCure Limited

NASDAQ:NVCR

$2.06B

Harrow Health, Inc.

NASDAQ:HROW

$1.40B

Teladoc Health, Inc.

NYSE:TDOC

$1.32B

Alvotech

NASDAQ:ALVO

$1.30B

Schrödinger, Inc.

NASDAQ:SDGR

$1.08B

Azenta, Inc.

NASDAQ:AZTA

$1.04B

Pacira BioSciences, Inc.

NASDAQ:PCRX

$904.31M

Tilray Brands, Inc.

NASDAQ:TLRY

$595.63M

What is the latest EVO filing?

The latest filing shown is 6-K dated May 6, 2026.

How many recent filings does EVO have?

Intrinsic Alpha currently shows 20 recent filings for EVO.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.